(Q34139014)

31 July 2017

1 reference

title

Pulmonary alveolar proteinosis: progress in the first 44 years (English)

1 reference

pulmonary alveolar proteinosis

31 July 2017

main subject

1 reference

John F Seymour

1

1 reference

31 July 2017

Jeffrey J Presneill

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

166

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

215-235

1 reference

Pulmonary alveolar proteinosis: clinical features and outcomes.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Alveolar proteinosis: diagnosis and treatment over a 10-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

The clinical and physiological effect of whole-lung lavage in pulmonary alveolar proteinosis: a ten-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Diagnosing pulmonary alveolar proteinosis. A review and an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis: a spectrum of cytologic, histochemical, and ultrastructural findings in bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis: high-resolution CT, chest radiographic, and functional correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

CT features of pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary Alveolar Proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

PULMONARY ALVEOLAR PROTEINOSIS. REPORT OF SIX CASES, REVIEW OF THE LITERATURE, AND FORMULATION OF A NEW THEORY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Diagnosis and management of alveolar proteinosis: the role of electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Cigarette smoking and other inhaled toxins in anti-GBM disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis: two contrasting cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Lung lavage (alveolar washing) in alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Alveolar proteinosis lung lavage using partial cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis. Diagnostic technics and observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary interstitial fibrosis associated with alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Bronchoalveolar lavage in interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pathogenesis of experimental pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Particulate concentrations in pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Clearance and recycling of pulmonary surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Mice unresponsive to GM-CSF are unexpectedly resistant to cutaneous Leishmania major infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Characterization of ovarian function in granulocyte-macrophage colony-stimulating factor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Effect of Granulocyte-Macrophage Colony-Stimulating Factor on the Generation of Epidermal Langerhans Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

The lavage fluid from a patient with alveolar proteinosis inhibits the in vitro chemiluminescence response and arachidonic acid metabolism of normal guinea pig alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Defective Lung Macrophages in Pulmonary Alveolar Proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis: abnormal in vitro function of alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Congenital alveolar proteinosis caused by a novel mutation of the surfactant protein B gene and misalignment of lung vessels in consanguineous kindred infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: evidence for a mutation hotspot in exon 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Focal congenital alveolar proteinosis associated with abnormal surfactant protein B messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

A mutation in the surfactant protein C gene associated with familial interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Genetic homogeneity of lysinuric protein intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

21 January 2018

Acute silicoproteinosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Sandblaster's lung with mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Acute silicosis due to inhalation of a domestic product

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis in association with household exposure to fibrous insulation material

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary Alveolar Proteinosis in a Painter With Elevated Pulmonary Concentrations of Titanium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pediatric population: a clinical, radiographic, and pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Alveolar lipoproteinosis in lung allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Exogenous lipid pneumonia related to smoking weed oil following cadaveric renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar lipoproteinosis complicating juvenile dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Are AIDS patients at risk for pulmonary alveolar proteinosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Secondary alveolar proteinosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary complications of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Severe alveolar proteinosis following chemotherapy for acute myeloid leukemia in a lung allograft recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Alveolar macrophage dysfunction in human bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary Alveolar Proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis causing severe hypoxemic respiratory failure treated with sequential whole-lung lavage utilizing venovenous extracorporeal membrane oxygenation: a case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

The cerebral complications of pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

21 January 2018

Cerebellar aspergilloma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis and Nocardia brain abscess. Report of a case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

THE ASSOCIATION OF NOCARDIOSIS AND PULMONARY ALVEOLAR PROTEINOSIS. A CASE STUDY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis with systemic nocardiosis. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Alveolar proteinosis and nocardiosis: a patient treated by bronchopulmonary lavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Treatment of nocardial infection with trimethoprim and sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Pulmonary alveolar proteinosis and histoplasmosis: report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Properties, Function and Origin of the Alveolar Lining Layer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Lipoprotein Composition of the Film lining the Lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

Natural and Therapy-Induced Anti-GM-CSF and Anti-G-CSF Antibodies in Human Serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109105

21 January 2018

Identifiers

DOI

10.1164/RCCM.2109105

1 reference

31 July 2017

1 reference